Results 161 to 170 of about 59,932 (250)

Remdesivir-Induced Marked Sinus Bradycardia in COVID-19 [PDF]

, 2022
Taimoor Ahmed, Samra Haroon Lodhi, Taha Ahmed   +2 more
openalex   +1 more source

Assessment of Clinical Efficacy of Early Use of Remdesivir in ThePatients of COVID-19 Pneumonia

, 2023

openalex   +1 more source

Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern

bioRxiv, 2021
L. Vangeel, Winston Chiu, S. de Jonghe, P. Maes, Bram Slechten, J. Raymenants, E. André, P. Leyssen, J. Neyts, D. Jochmans   +9 more
semanticscholar   +1 more source

BRINGING HOPE FOR COVID-19 – REMDESIVIR DRUG

, 2022
Gayatri Dhobale, Divya Argade, Ankita Badrike, Sanket N. Aher, Suresh Jadhav, Vishal Junnar, Seva Mandal', Gayatri   +7 more
openalex   +1 more source

Clinical impact of combination therapy with baricitinib, remdesivir, and dexamethasone in patients with severe COVID-19

, 2021
Takehiro Izumo, Naoyuki Kuse, Nobuyasu Awano, Mari Tone, Keita Sakamoto, Kohei Takada, Yutaka Muto, Kazushi Fujimoto, Ayae Saiki, Yu Ito, Haruko Matsumoto, Minoru Inomata   +11 more
openalex   +2 more sources

Remdesivir inhibits endothelial activation and atherosclerosis by coupling TAL1 to TRAF6

Journal of Translational Medicine
Background Atherosclerosis is characterized by complex pathological processes, including endothelial dysfunction and inflammation. The underlying pathogenic mechanisms have been well elucidated; however, effective treatments are yet to be validated.
Hanning Zhang, Ruru Li, Qianqian Huo, Li Li, Min Li, Shunxin Hu, Changjie Ren, Zongyin Wu, Chenghu Zhang   +8 more
doaj   +1 more source

The Effect of Remdesivir and Convalescent Plasma in Severe COVID-19 in Pregnancy [PDF]

, 2021
Elantably Ahmed, Dina Elantably, Ashraf Usman   +2 more
openalex   +1 more source

Comparable Efficacy of Lopinavir/Ritonavir and Remdesivir in Reducing Viral Load and Shedding Duration in Patients with COVID-19

Microorganisms
The spread of COVID-19 has significantly increased research on antiviral drugs and measures such as case isolation and contact tracing. This study compared the effects of lopinavir/ritonavir and remdesivir on COVID-19 patients with a control group ...
Choon-Mee Kim, Jae Keun Chung, Sadia Tamanna, Mi-Seon Bang, M. Tariq, You Mi Lee, Jun-Won Seo, Da Young Kim, N. Yun, Jinjong Seo, Yuri Kim, Min Ji Kim, Dong-Min Kim, Nam‐Hyuk Cho   +13 more
semanticscholar   +1 more source

In silico study of remdesivir with and without ionic liquids having different cations using DFT calculations and molecular docking

, 2022
Kamlesh Kumari, Ajay Kumar, Prashant Singh, Nagendra Kumar Kaushik   +3 more
openalex   +2 more sources

Persistent SARS-CoV-2 Infection in a Patient with Nephrotic Syndrome under Rituximab Therapy: Successful Treatment with a Combination of Remdesivir and Monoclonal Antibodies

, 2022
Akihiro Shimizu, Izumi Shirai, Kyohei Ogawa, Akane Miura, Kotaro Haruhara, Kentaro Oshiro, Akihiko Hamaguchi, Shinya Yokote, Masahiro Okabe, Hiroyuki Ueda, Nobuo Tsuboi, Masato Ikeda, Takashi Yokoo   +12 more
openalex   +2 more sources